-
ESPR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Esperion Therapeutics (ESPR)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 144.76 mm | 144.76 mm | 144.76 mm | 144.76 mm | 144.76 mm | 144.76 mm |
Cash burn (monthly) | (no burn) | (no burn) | 1.47 mm | (no burn) | 11.65 mm | 1.97 mm |
Cash used (since last report) | n/a | n/a | 3.51 mm | n/a | 27.76 mm | 4.70 mm |
Cash remaining | n/a | n/a | 141.25 mm | n/a | 117.00 mm | 140.06 mm |
Runway (months of cash) | n/a | n/a | 95.9 | n/a | 10.0 | 71.1 |
13F holders | Current |
---|---|
Total holders | 195 |
Opened positions | 33 |
Closed positions | 26 |
Increased positions | 57 |
Reduced positions | 45 |
13F shares | Current |
---|---|
Total value | 273.35 bn |
Total shares | 142.04 mm |
Total puts | 1.27 mm |
Total calls | 1.78 mm |
Total put/call ratio | 0.7 |
Largest owners | Shares | Value |
---|---|---|
Wasatch Advisors | 24.48 mm | $53.86 bn |
BlackRock | 14.24 mm | $31.32 bn |
Vanguard | 11.72 mm | $25.77 bn |
BBBOF BB Biotech | 9.94 mm | $18.00 mm |
BLVGF Bellevue | 9.94 mm | $21.88 bn |
MS Morgan Stanley | 6.31 mm | $13.88 bn |
Kairos Capital Management | 6.23 mm | $13.71 bn |
Flynn James E | 5.00 mm | $0.00 |
STT State Street | 4.50 mm | $9.91 bn |
Geode Capital Management | 4.34 mm | $9.55 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
19 Feb 25 | Benjamin Halladay | Common Stock | Sell | Dispose S | No | No | 1.86 | 11 | 20.46 | 240,671 |
19 Feb 25 | Eric Warren | Common Stock | Sell | Dispose S | No | No | 1.868 | 239 | 446.45 | 159,759 |
17 Jan 25 | Eric Warren | Common Stock | Sell | Dispose S | No | No | 2.26 | 123 | 277.98 | 159,998 |
17 Jan 25 | Benjamin Halladay | Common Stock | Sell | Dispose S | No | No | 2.265 | 9 | 20.39 | 240,682 |
17 Dec 24 | Sheldon L. Koenig | Common Stock | Sell | Dispose S | No | No | 2.466 | 12,447 | 30.69 k | 739,819 |